Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

73.15 +1.01 (+1.40%)
Official Closing Price Updated: 7:00 PM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
CVS Stock Flashes Golden Cross As Weight Loss Program Delivers Big Results
CVS Health Corp. flashing bullish signal with Golden Cross formation and strong technicals. Weight management program also gaining traction. 
Via Benzinga
Allegations of Inflated Prescription Drug Costs Spark Employee Lawsuit Against JPMorgan
A lawsuit has been lodged against JPMorgan Chase by its employees, who claim that the company's prescription drug plan consented to pay exorbitant prices for medications. 
Via Benzinga
Topics Lawsuit
CVS Weight Management Program Yields 15% Average Weight Loss, 26% Cost Saving Among Participants
CVS Weight Management program members achieved 15% average weight loss, with 92% satisfaction and 26% lower GLP-1 medication costs for participating clients. 
Via Benzinga
Inflation Isn’t Going Away, But These Sectors Don’t Care
The CPI and PPI releases this week came in more or less at estimates - nothing to alarm the talking heads, anyway. They show inflation slowing down but not receding. 
Via Talk Markets
Topics ETFs Economy Stocks / Equities
Is CVS Health Gaining or Losing Market Support?
 
Via Benzinga
CVS Health Options Trading: A Deep Dive into Market Sentiment
 
Via Benzinga
Has CVS Health Stock Turned Things Around?
Via The Motley Fool
Spotlight on CVS Health: Analyzing the Surge in Options Activity
 
Via Benzinga
Palantir Stock Climbs As Wall Street Eyes New Artificial Intelligence Customers At AIPCon
Palantir stock climbed as analysts focused on potential new customers such as Walgreens at an artificial intelligence event called AIPCon. 
Via Investor's Business Daily
Topics Artificial Intelligence
These 3 Dividend Stocks Jumped 15% in a Month—More to Come?
Via MarketBeat
Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet
Walgreens Boots Alliance agreed to an $11.45 per share buyout by Sycamore Partners, but shareholders can reject the deal and holdout for a better offer. 
Via MarketBeat
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
 
Via Benzinga
Behind the Scenes of CVS Health's Latest Options Trends
 
Via Benzinga
Behind the Scenes of CVS Health's Latest Options Trends
 
Via Benzinga
Is It Too Late to Buy CVS Health Stock for the High-Yield Dividend?
Via The Motley Fool
CVS Health (CVS): Buy, Sell, or Hold Post Q4 Earnings?
CVS Health has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.4%. The stock now trades at $65.60, marking a 15.2% gain. This was partly thanks to its solid... 
Via StockStory
Topics Stocks
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week
Speculation over an impending reverse merger, a Phase 2 trial announcement, comments about upcoming cancer screening tests, a Medicare business deal, and an obesity drug partnership sparked buzz among... 
Via Stocktwits
The Smartest Dividend Stocks to Buy With $3,000 Right Now
Via The Motley Fool
CVS: One Stock Superinvestors Are Loading Up On
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. 
Via Talk Markets
Topics Stocks / Equities
3 Beaten Down Healthcare Stocks Recovering in 2025
Healthcare stocks took a tumble in 2024 as rising medical costs did a number on margins and profitability, but 2025 may be the year they rebound. 
Via MarketBeat
CVS: Stock Pops In A Tough Market...But Should You Buy It?
Via Talk Markets
Topics Stocks / Equities
5 Best Stocks Powering S&P 500 ETF Midway In Q1
After a stellar 2024, the S&P 500 has been on a bullish trend this year, too. 
Via Talk Markets
Topics ETFs Stocks Stocks / Equities
These S&P500 stocks are moving in today's pre-market session
Curious about the S&P500 stocks that are showing activity before the opening bell on Friday? 
Via Chartmill
DOJ Investigates UnitedHealth, Probe Accuses Of Inflating Medicare Diagnoses
The Justice Department is investigating UnitedHealth's Medicare billing practices, focusing on diagnoses that led to higher federal payments. The probe follows reports that the company received... 
Via Benzinga
Humana Gains Despite Medicare Advantage Losses—What’s the Catch?
Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10% 
Via MarketBeat
These Were the 5 Top-Performing Stocks in the S&P 500 in January 2025
Via The Motley Fool
Topics Stocks
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Super Micro Computer, Intel, Alibaba And CVS Are Among Top 13 Large-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
In the last week, these 13 large-cap stocks were top performers. Are they in your portfolio? HIMS, AUR, APP, SMCI, TEM, DKNG, INTC, MNDY, BROS, CVS, BABA, AAPL, ABNB. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Why CVS Stock Thrashed the Market on Thursday
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback